BACKGROUND: There is a paucity of randomized studies evaluating the value of palliative interventions on a prospective basis in newly diagnosed oncology patients. We sought to prospectively evaluate quality of life (QoL) outcomes in advanced cancer patients who receiveddiscussion-based palliative care interventions from an advanced registered nurse practitioner (ARNP) integrated into the oncology team, and compare these outcomes with a control population. METHODS:Patients with metastatic cancer were randomized to standard care or an ARNP-directed intervention that included discussions of the benefits of hospice, discussions on living wills and advanced directives (Five Wishes document) along with an assessment of QoL. Relevant endpoints included change from baseline QoL and improvement in hospice knowledge. RESULTS:From November 13, 2008, through July 28, 2009, 26 patients were accrued at the Mayo Clinic in Jacksonville, Florida. The study closed early due to published data demonstrating the benefits of early palliative care interventions in the management of metastatic cancer patients. Statistically significant improvements from baseline were noted in emotional and mental QoL assessments in the intervention group that were not seen in the control group. Patients found it useful to have the living will and Five Wishes documents offered as part of the ARNP intervention. CONCLUSIONS: An ARNP-directed intervention that explains the benefits of hospice and addresses advanced directives early in the course of metastatic cancer patients' treatment, is well received by the patients and their relatives and leads to measurable improvement in the patient's emotional and mental QoL.
RCT Entities:
BACKGROUND: There is a paucity of randomized studies evaluating the value of palliative interventions on a prospective basis in newly diagnosed oncology patients. We sought to prospectively evaluate quality of life (QoL) outcomes in advanced cancerpatients who received discussion-based palliative care interventions from an advanced registered nurse practitioner (ARNP) integrated into the oncology team, and compare these outcomes with a control population. METHODS:Patients with metastatic cancer were randomized to standard care or an ARNP-directed intervention that included discussions of the benefits of hospice, discussions on living wills and advanced directives (Five Wishes document) along with an assessment of QoL. Relevant endpoints included change from baseline QoL and improvement in hospice knowledge. RESULTS: From November 13, 2008, through July 28, 2009, 26 patients were accrued at the Mayo Clinic in Jacksonville, Florida. The study closed early due to published data demonstrating the benefits of early palliative care interventions in the management of metastatic cancerpatients. Statistically significant improvements from baseline were noted in emotional and mental QoL assessments in the intervention group that were not seen in the control group. Patients found it useful to have the living will and Five Wishes documents offered as part of the ARNP intervention. CONCLUSIONS: An ARNP-directed intervention that explains the benefits of hospice and addresses advanced directives early in the course of metastatic cancerpatients' treatment, is well received by the patients and their relatives and leads to measurable improvement in the patient's emotional and mental QoL.
Authors: Joan M Teno; Janet E Shu; David Casarett; Carol Spence; Ramona Rhodes; Stephen Connor Journal: J Pain Symptom Manage Date: 2007-06-21 Impact factor: 3.612
Authors: Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: M Bretscher; T Rummans; J Sloan; J Kaur; A Bartlett; L Borkenhagen; C Loprinzi Journal: Psychosomatics Date: 1999 Jul-Aug Impact factor: 2.386
Authors: Marvin O Delgado-Guay; David Hui; Henrique A Parsons; Kathy Govan; Maxine De la Cruz; Steven Thorney; Eduardo Bruera Journal: J Pain Symptom Manage Date: 2011-03-12 Impact factor: 3.612
Authors: J C Weeks; E F Cook; S J O'Day; L M Peterson; N Wenger; D Reding; F E Harrell; P Kussin; N V Dawson; A F Connors; J Lynn; R S Phillips Journal: JAMA Date: 1998-06-03 Impact factor: 56.272
Authors: Marie Bakitas; Kathleen Doyle Lyons; Mark T Hegel; Stefan Balan; Frances C Brokaw; Janette Seville; Jay G Hull; Zhongze Li; Tor D Tosteson; Ira R Byock; Tim A Ahles Journal: JAMA Date: 2009-08-19 Impact factor: 56.272
Authors: D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon Journal: J Clin Oncol Date: 1993-03 Impact factor: 44.544
Authors: Stephen H Taplin; Sallie Weaver; Eduardo Salas; Veronica Chollette; Heather M Edwards; Suanna S Bruinooge; Michael P Kosty Journal: J Oncol Pract Date: 2015-04-14 Impact factor: 3.840
Authors: Dio Kavalieratos; Jennifer Corbelli; Di Zhang; J Nicholas Dionne-Odom; Natalie C Ernecoff; Janel Hanmer; Zachariah P Hoydich; Dara Z Ikejiani; Michele Klein-Fedyshin; Camilla Zimmermann; Sally C Morton; Robert M Arnold; Lucas Heller; Yael Schenker Journal: JAMA Date: 2016-11-22 Impact factor: 56.272
Authors: Veerawat Phongtankuel; Lauren Meador; Ronald D Adelman; Jordan Roberts; Charles R Henderson; Sonal S Mehta; Tessa Del Carmen; M C Reid Journal: Am J Hosp Palliat Care Date: 2016-11-10 Impact factor: 2.500
Authors: Natalie C Ernecoff; Devon Check; Megan Bannon; Laura C Hanson; James Nicholas Dionne-Odom; Jennifer Corbelli; Michele Klein-Fedyshin; Yael Schenker; Camilla Zimmermann; Robert M Arnold; Dio Kavalieratos Journal: J Palliat Med Date: 2019-10-23 Impact factor: 2.947
Authors: Mary Lesperance; Robert Shannon; Phyllis K Pumphrey; Erin Dunbar; Renee Genther; C Lynn Coleman; Margaret Tabano; Jennifer Maurer; Adrienne Vazquez; Elizabeth Capp; Jessica McMillan; Katie Wilkerson; Gerald Robbins; Dorothy Green Phillips; Priscilla Howick; Catherine Solaun; Jeff Sloan; Gerardo Colón-Otero Journal: Am J Hosp Palliat Care Date: 2013-04-23 Impact factor: 2.500